The development of cancer imaging with radiolabeled antibodies, or radioimmunodetection (RAID), has spanned at least 2 decades, if we begin dating this from the use of antibodies made against human tumor-associated antigens, such as oncofetal
David M. Goldenberg, SCD, MD
Advertisement
Articles by David M. Goldenberg, SCD, MD
Advertisement
Latest Updated Articles
- Commentary (Goldenberg): Diagnostic Use of Radiolabeled Antibodies for Cancer
Published: July 1st 1995 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Could Scorpion Venom Component Play a Role in Glioblastoma Management?
2
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC
3
Chlorotoxin-Directed Cell Therapy May Have Useful Mechanism in Glioblastoma
4
How Dato-DXd and the TROPION Trials Are Transforming Solid Tumor Research
5
